Arcus Biosciences Quarterly Income Statements Chart
Quarterly
|
Annual
Arcus Biosciences Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| revenues: | ||||||||||||||||||||||||||||||
| license and development services revenue | 152,000,000 | 20,000,000 | 51,000,000 | 41,000,000 | 28,000,000 | 135,000,000 | ||||||||||||||||||||||||
| other collaboration revenue | 8,000,000 | 8,000,000 | 8,000,000 | 7,000,000 | 11,000,000 | 10,000,000 | 9,000,000 | 10,000,000 | 10,000,000 | 8,000,000 | 8,029,000 | 9,839,000 | 10,066,000 | 10,066,000 | ||||||||||||||||
| total revenues | 160,000,000 | 28,000,000 | 26,000,000 | 48,000,000 | 39,000,000 | 145,000,000 | 31,000,000 | 32,000,000 | 29,000,000 | 25,000,000 | 33,655,000 | 33,581,000 | 26,759,000 | 18,005,000 | 7,095,750 | 9,461,000 | ||||||||||||||
| operating expenses: | ||||||||||||||||||||||||||||||
| research and development | 139,000,000 | 122,000,000 | 101,000,000 | 123,000,000 | 115,000,000 | 109,000,000 | 93,000,000 | 82,000,000 | 84,000,000 | 81,000,000 | 80,200,000 | 76,684,000 | 69,905,000 | 61,211,000 | 49,936,000 | 71,254,000 | 68,771,000 | 66,387,000 | 48,712,000 | 51,801,000 | 35,693,000 | 23,142,000 | 20,686,000 | 17,241,000 | 24,999,000 | 15,554,000 | 11,436,000 | 12,859,000 | 13,699,000 | 11,652,000 |
| general and administrative | 29,000,000 | 28,000,000 | 28,000,000 | 30,000,000 | 30,000,000 | 32,000,000 | 29,000,000 | 30,000,000 | 28,000,000 | 30,000,000 | 27,896,000 | 26,294,000 | 25,836,000 | 23,974,000 | 23,296,000 | 16,343,000 | 16,826,000 | 15,821,000 | 12,787,000 | 11,177,000 | 11,432,000 | 7,008,000 | 6,591,000 | 7,758,000 | 5,911,000 | 4,969,000 | 3,610,000 | 3,577,000 | 3,450,000 | 2,929,000 |
| impairment of long-lived assets | 20,000,000 | |||||||||||||||||||||||||||||
| total operating expenses | 168,000,000 | 150,000,000 | 129,000,000 | 153,000,000 | 145,000,000 | 161,000,000 | 122,000,000 | 112,000,000 | 112,000,000 | 111,000,000 | 108,096,000 | 102,978,000 | 95,741,000 | 85,185,000 | 73,232,000 | 87,597,000 | 85,597,000 | 82,208,000 | 61,499,000 | 62,978,000 | 47,125,000 | 30,150,000 | 27,277,000 | 24,999,000 | 30,910,000 | 20,523,000 | 15,046,000 | 16,436,000 | 17,149,000 | 14,581,000 |
| income from operations | -8,000,000 | -122,000,000 | -103,000,000 | -105,000,000 | -106,000,000 | -16,000,000 | -91,000,000 | -80,000,000 | -83,000,000 | -86,000,000 | -74,441,000 | -69,397,000 | -68,982,000 | -67,180,000 | 281,267,000 | -78,136,000 | -76,136,000 | -72,747,000 | -52,012,000 | 1,552,000 | -45,375,000 | -28,400,000 | -17,527,000 | -23,249,000 | -29,160,000 | -18,773,000 | -13,484,000 | -12,145,000 | -15,899,000 | -13,331,000 |
| yoy | -92.45% | 662.50% | 13.19% | 31.25% | 27.71% | -81.40% | 22.24% | 15.28% | 20.32% | 28.01% | -126.47% | -11.18% | -9.40% | -7.65% | -640.77% | -5134.54% | 67.79% | 156.15% | 196.75% | -106.68% | 55.61% | 51.28% | 29.98% | 91.43% | 83.41% | 40.82% | ||||
| qoq | -93.44% | 18.45% | -1.90% | -0.94% | 562.50% | -82.42% | 13.75% | -3.61% | -3.49% | 15.53% | 7.27% | 0.60% | 2.68% | -123.88% | -459.97% | 2.63% | 4.66% | 39.87% | -3451.29% | -103.42% | 59.77% | 62.04% | -24.61% | -20.27% | 55.33% | 39.22% | 11.03% | -23.61% | 19.26% | |
| operating margin % | ||||||||||||||||||||||||||||||
| non-operating income: | ||||||||||||||||||||||||||||||
| interest and other income | 10,000,000 | 11,000,000 | 12,000,000 | 14,000,000 | 13,000,000 | 13,000,000 | 11,000,000 | 12,000,000 | 9,000,000 | 9,000,000 | 7,544,000 | 5,013,000 | 2,861,000 | 582,000 | 176,000 | 161,000 | 166,000 | 154,000 | 159,000 | 270,000 | 301,000 | 647,000 | 929,000 | 1,254,000 | 1,482,000 | 1,534,000 | 846,000 | 1,333,000 | 2,366,000 | 377,000 |
| interest expense | -2,000,000 | -1,000,000 | -2,000,000 | -1,000,000 | ||||||||||||||||||||||||||
| total non-operating income | 8,000,000 | 10,000,000 | 10,000,000 | 13,000,000 | 13,000,000 | 12,000,000 | 11,000,000 | 11,000,000 | 9,000,000 | 8,000,000 | 6,981,000 | 4,478,000 | 2,350,000 | 191,000 | -84,000 | 161,000 | 166,000 | 154,000 | 159,000 | 270,000 | 301,000 | 647,000 | 929,000 | 897,000 | 1,070,000 | 1,103,000 | ||||
| income before income taxes | -112,000,000 | -93,000,000 | -92,000,000 | -93,000,000 | -4,000,000 | -80,000,000 | -69,000,000 | -74,000,000 | -78,000,000 | |||||||||||||||||||||
| income tax expense | -1,000,000 | -2,000,000 | -1,000,000 | -2,000,000 | 4,000 | -1,004,000 | ||||||||||||||||||||||||
| net income | -112,000,000 | -94,000,000 | -92,000,000 | -93,000,000 | -4,000,000 | -81,000,000 | -71,000,000 | -75,000,000 | -80,000,000 | -67,456,000 | -64,919,000 | -66,632,000 | -67,993,000 | 279,368,000 | -77,975,000 | -75,970,000 | -72,593,000 | -51,853,000 | 1,822,000 | -45,074,000 | -27,753,000 | -16,598,000 | -22,352,000 | -28,090,000 | -17,670,000 | -12,295,000 | -10,812,000 | -13,533,000 | -12,954,000 | |
| yoy | 2700.00% | 16.05% | 29.58% | 24.00% | -95.00% | 20.08% | 9.37% | 12.56% | 17.66% | -124.15% | -16.74% | -12.29% | -6.34% | -638.77% | -4379.64% | 68.55% | 161.57% | 212.41% | -108.15% | 60.46% | 57.06% | 35.00% | 106.73% | 107.57% | 36.41% | |||||
| qoq | 19.15% | 2.17% | -1.08% | 2225.00% | -95.06% | 14.08% | -5.33% | -6.25% | 18.60% | 3.91% | -2.57% | -2.00% | -124.34% | -458.28% | 2.64% | 4.65% | 40.00% | -2945.94% | -104.04% | 62.41% | 67.21% | -25.74% | -20.43% | 58.97% | 43.72% | 13.72% | -20.11% | 4.47% | ||
| net income margin % | ||||||||||||||||||||||||||||||
| net income per share | -0.695 | -0.9 | -0.93 | -0.96 | 4.04 | -1.11 | -1.09 | -1.08 | -0.87 | 0.03 | -0.93 | -0.63 | -0.37 | -0.51 | -0.64 | -0.41 | -0.27 | -0.25 | -0.32 | -1.37 | ||||||||||
| basic | ||||||||||||||||||||||||||||||
| diluted | ||||||||||||||||||||||||||||||
| shares used to compute net income per share: | ||||||||||||||||||||||||||||||
| basic | 106.1 | |||||||||||||||||||||||||||||
| diluted | 106.5 | |||||||||||||||||||||||||||||
| net income per share | -0.695 | -0.9 | -0.93 | -0.96 | 4.04 | -1.11 | -1.09 | -1.08 | -0.87 | 0.03 | -0.93 | -0.63 | -0.37 | -0.51 | -0.64 | -0.41 | -0.27 | -0.25 | -0.32 | -1.37 | ||||||||||
| basic and diluted | -1.14 | -1.03 | -1 | -1.02 | -0.05 | -0.768 | -0.94 | -1.04 | -1.09 | |||||||||||||||||||||
| shares used to compute net income per share: | ||||||||||||||||||||||||||||||
| basic and diluted | 98.4 | 0.5 | 91.4 | 91.1 | 86.2 | 18.4 | 74.6 | 73.2 | 73 | |||||||||||||||||||||
| effective interest on liability for sale of future royalties | -1,000,000 | -1,000,000 | -1,000,000 | -563,000 | -535,000 | -511,000 | -391,000 | |||||||||||||||||||||||
| license and development service revenue | 22,000,000 | 22,000,000 | 19,000,000 | 17,000,000 | 25,626,000 | 23,742,000 | 16,693,000 | 7,939,000 | ||||||||||||||||||||||
| net income before income taxes | -49,635,000 | -64,919,000 | -66,632,000 | -66,989,000 | ||||||||||||||||||||||||||
| other comprehensive loss | -2,135,000 | -2,557,000 | -2,584,000 | -3,399,000 | -55,000 | |||||||||||||||||||||||||
| comprehensive loss | -52,021,000 | -67,476,000 | -69,216,000 | -71,392,000 | -76,014,000 | -72,639,000 | -45,218,000 | -27,529,000 | -16,587,000 | -22,411,000 | -28,006,000 | -17,534,000 | -12,294,000 | -10,837,000 | -13,519,000 | -13,009,000 | ||||||||||||||
| net income per share | -0.695 | -0.9 | -0.93 | -0.96 | 4.04 | -1.11 | -1.09 | -1.08 | -0.87 | 0.03 | -0.93 | -0.63 | -0.37 | -0.51 | -0.64 | -0.41 | -0.27 | -0.25 | -0.32 | -1.37 | ||||||||||
| weighted-average number of shares used to compute basic and diluted net income per share | 72,236,283 | 71,814,232 | 71,194,778 | 69,745,297 | 67,082,161 | 54,787,118 | 48,556,843 | 44,282,607 | 43,825,991 | 43,939,281 | 43,797,718 | 43,508,592 | 34,618,237 | 42,838,098 | 42,533,641 | 9,488,352 | ||||||||||||||
| license revenue | ||||||||||||||||||||||||||||||
| collaboration revenue | 7,095,750 | 9,461,000 | 9,461,000 | 9,461,000 | ||||||||||||||||||||||||||
| gain on deemed sale from equity method investee | 131,000 | 482,000 | ||||||||||||||||||||||||||||
| share of income from equity method investee | -131,000 | -482,000 | -357,000 | -412,000 | -431,000 | |||||||||||||||||||||||||
| other comprehensive income | -1,169,000 | -46,000 | -44,000 | -46,000 | -37,000 | -63,000 | -144,000 | 224,000 | 11,000 | -59,000 | 84,000 | 136,000 | -16,500 | -25,000 | 14,000 | |||||||||||||||
| comprehensive income | 278,199,000 | -78,021,000 | -17,747,000 | 1,759,000 | ||||||||||||||||||||||||||
| weighted-average number of shares used to compute basic net income per share | 69,345,490 | 70,110,138 | 62,599,193 | |||||||||||||||||||||||||||
| weighted-average number of shares used to compute diluted net income per share | 73,966,267 | 70,110,138 | 65,145,707 | |||||||||||||||||||||||||||
| total collaboration and license revenues | 9,461,000 | 9,461,000 | ||||||||||||||||||||||||||||
| collaboration and license revenue | 17,007,500 | 64,530,000 | 1,750,000 | 1,750,000 | 9,750,000 | 1,750,000 | 1,750,000 | 1,750,000 | 1,562,000 | 4,291,000 | 1,250,000 | 1,250,000 | ||||||||||||||||||
| operation expenses: |
We provide you with 20 years income statements for Arcus Biosciences stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Arcus Biosciences stock. Explore the full financial landscape of Arcus Biosciences stock with our expertly curated income statements.
The information provided in this report about Arcus Biosciences stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.